Media Coverage

N-of-1 Drugs Push Biopharma Frontiers

N-of-1 Drugs Push Biopharma Frontiers

Nature

Bespoke drug development could have regulatory, toxicology and accessibility implications for the entire biopharma sector.

Read the Full Article